Ignite Creation Date:
2024-07-17 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06472388
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-03
Brief Title:
Everolimus 5 mg vs 10 mgDaily for Patients With Neuroendocrine Tumors
Sponsor:
AC Camargo Cancer Center
Organization:
AC Camargo Cancer Center
Organization Data
Organization:
AC Camargo Cancer Center
Class:
OTHER
Study ID:
67420523410015432
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AC Camargo Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Rachel Riechelmann
Responsible Party Title:
Dr
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
AC Camargo Cancer Center
Old Name:
None
Old Organization:
None